cancer treatment
Research Topic
Language: English
This is a research topic created to provide authors with a place to attach new problem publications.
Research topics above this in the hierarchy
Research problems linked to this topic
- Intratumour heterogeneity is increasingly recognized as a frequent problem for cancer treatment as it allows for the evolution of resistance against treatment.
- The development of resistance to chemotherapy is a major obstacle for lasting effective treatment of cancer.
- Nausea and vomiting are ranked as the most severe side effects to chemotherapy by cancer patients.
- Acquired drug resistance represents a major obstacle to effective cancer treatment.
- Anti-cancer therapies frequently lead to ovarian damage and impaired fertility.
- The incidence rate of cancer is steadily increasing all around the world, and there is an urgent need to develop novel and more effective treatment strategies.
- The efficacy of cancer chemotherapy is often affected by the emergence of resistant cancer cells.
- Many people with cancer experience moderate to severe pain that requires treatment with strong opioids, such as oxycodone and morphine.
- Skin toxicity is a frequent side effect of radio and chemo-treatments in patients treated for breast cancer after conservative surgery.
- The main challenge of cancer therapy is certainly to develop therapy with higher specificity for target tissues or cells.
- A major barrier to the successful application of nanotechnology for cancer treatment is the suboptimal delivery of therapeutic payloads to metastatic tumor deposits.
- Everolimus-related interstitial lung disease (ILD) (also: pneumonitis) poses a difficulty for physicians, as it is hard to discriminate ILD from other causes of respiratory symptoms and to decide on safe treatment continuation.
- Breast cancer resistance protein (BCRP, ABCG2) is one of the ATP binding cassette (ABC) transporter proteins which involved in multi-drug resistance of cancer therapy.
- Prior studies have shown that worry about recurrence is a common problem during cancer treatment and survivorship and may be associated with symptom response and surveillance after primary treatment.